The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and toxicity of extending bone modifying agents beyond two years for bone metastases in breast or castrate-resistant prostate cancer patients: A systematic review.
 
Terry L. Ng
Honoraria - ARIAD; ARIAD/Takeda
Consulting or Advisory Role - Boehringer Ingelheim
 
Megan M. Tu
No Relationships to Disclose
 
Mohammed FK Ibrahim
No Relationships to Disclose
 
Bassam Mohammed Basulaiman
Honoraria - Amgen; AstraZeneca
Travel, Accommodations, Expenses - Janssen Oncology; Roche
 
Sharon McGee
No Relationships to Disclose
 
Amirrtha Srikanthan
No Relationships to Disclose
 
Ricardo Fernandes
Honoraria - Bayer; Bayer; Merck; Pfizer
Consulting or Advisory Role - Bayer; Janssen; Novartis Canada Pharmaceuticals Inc; Pfizer
Travel, Accommodations, Expenses - Janssen
 
Lisa Vandermeer
No Relationships to Disclose
 
Carol Stober
No Relationships to Disclose
 
Marta Sienkiewicz
No Relationships to Disclose
 
Ahwon Jeong
No Relationships to Disclose
 
Deanna Saunders
No Relationships to Disclose
 
Arif Ali Awan
Honoraria - Apotex
Consulting or Advisory Role - Novartis Canada Pharmaceuticals Inc
Travel, Accommodations, Expenses - Roche/Genentech; Roche/Genentech
 
Brian Hutton
No Relationships to Disclose
 
Mark J. Clemons
No Relationships to Disclose